Study of IO#2.

Trial Profile

Study of IO#2.

Phase of Trial: Phase I

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Anti GITR immunotherapy OncoMed (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jan 2017 New trial record
    • 31 Dec 2016 According to an OncoMed Pharmaceuticals media release, company has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top